Hepatology (Baltimore, Md.)
A randomized controlled trial of stepped treatment to reduce unhealthy alcohol use in patients with chronic liver disease.
Vitamin E dosing study (VEDS) in patients with metabolic dysfunction-associated steatotic liver disease with elevated aminotransferases: A multicenter, randomized, placebo-controlled trial.
AASLD AST Practice Guideline on adult liver transplantation: Candidate evaluation.
Sex and body size disparities under MELD 3.0: Evaluation of persisting gaps in liver transplant access.
Integrative hepatology: Enhancing overall health to manage liver disease.
Salivary microbiome and serum metabolomics add to clinical biomarkers to predict 6-month hospitalizations in a multicenter cirrhosis outpatient cohort.
Reply: Considerations on the use of LPCN 1148 in cirrhotic patients with sarcopenia.
The Liver Transplant Comorbidity Index (LTCI) : A composite index of ambulatory Pre-LT factors to identify patients at increased risk of Post-LT Mortality.
A prospective multicenter validation of RETREAT for posttransplantation HCC recurrence prediction.
Reply: Downstaging of hepatocellular carcinoma before liver transplantation.
